Literature DB >> 2453971

A comparative immunohistochemical study of cytokeratin and vimentin expression in middle ear mucosa and cholesteatoma, and in epidermis.

D Broekaert1, A Cornille, H Eto, I Leigh, F Ramaekers, G Van Muijen, P Coucke, J De Bersaques, P Kluyskens, E Gillis.   

Abstract

Cytokeratin expression was studied in human middle ear cholesteatoma lesions, using a variety of immunohistological techniques and a wide range of polyclonal antisera and monoclonal antibodies against cytokeratin (CK) subgroups or individual CK polypeptides. The expression of the other cytoskeletal proteins, vimentin and desmin, was also investigated. Middle ear mucosa and epidermal tissues were used as reference tissues. Our investigations also included epithelial structures present in the cholesteatoma perimatrix and in dermal tissues. The results indicate that, compared with epidermal tissues, the expression profile of CKs in cholesteatoma matrix is representative of a hyperproliferative disease. Evaluating the presence of a marker of terminal keratinization - the 56.5 kD acidic CK n degrees 10 - we found supportive evidence of a pronounced retardation of its expression, which did not parallel histological differentiation. In epidermal tissues, the first prickle cell layers are CK10 positive whereas in many cholesteatomas this finding was observed near the stratum granulosum only. Probing the early stages of keratinization - the 58 kD basic CK n degrees 5 and the 50 kD acidic CK n degrees 14 - we regularly observed an extended staining area in the cholesteatoma matrix. In epidermal reference tissues, only the basal and nearest suprabasal layers were convincingly labeled. As a rule, non-epidermal CKs did not belong to the cholesteatoma CK set. However, exceptions to that rule were noticed as a focal or more extended expression of one or more non-epidermal CKs in about half of the cases. Together with the extended CK5 topography, this is further evidence that CK expression is seriously affected by the diseased state. CK expression in the perimatrix is limited to mucous glands, either normal, atrophic or hyperplastic. CKs n degrees 4, 5, 7, 14, 18 and 19, also displayed by middle ear mucosa, were consistently observed. Where ductal arrangements were present, CK10 was also detected, in analogy with the CK10 registration in ductal portions of mucous glands in the external ear canal skin. The absence of CK8 in mucous glands of the perimatrix, however, strongly differentiates these structures from the mucous gland acini and ducti in the external ear canal, where CK8 is systematically expressed. Vimentin staining was restricted to dendritic cells of the matrix (Langerhans cells) and to perimatrix fibroblasts, blood cells and vascular endothelium. Coexpression of CK and vimentin was not observed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2453971     DOI: 10.1007/bf00844280

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  33 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 2.  Cytoskeleton: definition, structure and gene regulation.

Authors:  K Weber; M Osborn
Journal:  Pathol Res Pract       Date:  1982       Impact factor: 3.250

3.  Epidermal Langerhans cells contain intermediate-sized filaments of the vimentin type: an immunocytologic study.

Authors:  R M de Waal; J T Semeijn; M H Cornelissen; F C Ramaekers
Journal:  J Invest Dermatol       Date:  1984-06       Impact factor: 8.551

4.  Cytoskeletal differences between human neuroendocrine tumors: a cytoskeletal protein of molecular weight 46,000 distinguishes cutaneous from pulmonary neuroendocrine neoplasms.

Authors:  R Moll; W W Franke
Journal:  Differentiation       Date:  1985       Impact factor: 3.880

5.  Monoclonal antikeratin antibody: production, characterization, and immunohistochemical application.

Authors:  H Eto; K Hashimoto; H Kobayashi; M Matsumoto; T Kanzaki; A H Mehregan; R A Weiss
Journal:  J Invest Dermatol       Date:  1985-05       Impact factor: 8.551

6.  Immunocytochemical and ultrastructural localization of keratin polypeptides in normal epidermal and mucosal cells and tissues.

Authors:  T Loening; M J Staquet; D Schmitt; J Thivolet
Journal:  J Invest Dermatol       Date:  1982-01       Impact factor: 8.551

7.  Monoclonal antibodies with different specificities against cytokeratins. An immunohistochemical study of normal tissues and tumors.

Authors:  G N van Muijen; D J Ruiter; M Ponec; C Mey; S O Warnaar
Journal:  Am J Pathol       Date:  1984-01       Impact factor: 4.307

8.  Monoclonal antibody to keratin filaments, specific for glandular epithelia and their tumors. Use in surgical pathology.

Authors:  F Ramaekers; A Huysmans; O Moesker; A Kant; P Jap; C Herman; P Vooijs
Journal:  Lab Invest       Date:  1983-09       Impact factor: 5.662

Review 9.  Antibodies to intermediate filament proteins in the immunohistochemical identification of human tumours: an overview.

Authors:  F C Ramaekers; J J Puts; O Moesker; A Kant; A Huysmans; D Haag; P H Jap; C J Herman; G P Vooijs
Journal:  Histochem J       Date:  1983-07

10.  Tissue distribution of keratin 7 as monitored by a monoclonal antibody.

Authors:  F Ramaekers; A Huysmans; G Schaart; O Moesker; P Vooijs
Journal:  Exp Cell Res       Date:  1987-05       Impact factor: 3.905

View more
  11 in total

1.  An investigation of cytokeratin expression in skin epithelial cysts and some uncommon types of cystic tumours using chain-specific antibodies.

Authors:  D Broekaert; L Goeman; F C Ramaekers; G N Van Muijen; H Eto; E B Lane; I M Leigh; J De Bersaques; P Coucke
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

2.  Antikeratin 14 monoclonal antibody staining in psoriasis and seborrhoeic keratosis: immunofluorescence and two colour FACS studies.

Authors:  H Wongwaisayawan; T Yoshiike; Y Aikawa; R A Briggaman; H Ogawa
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

3.  Optical imaging with a high-resolution microendoscope to identify cholesteatoma of the middle ear.

Authors:  Lauren L Levy; Nancy Jiang; Eric Smouha; Rebecca Richards-Kortum; Andrew G Sikora
Journal:  Laryngoscope       Date:  2013-01-08       Impact factor: 3.325

4.  Keratinization of middle ear cholesteatomas. I. A histochemical study of epidermal transglutaminase.

Authors:  D Broekaert; C Pattin; P Coucke; J De Bersaques; J Marquet
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

5.  Keratinization of middle ear cholesteatomas. II. A histochemical study of epidermal transglutaminase substrates.

Authors:  D Broekaert; P Coucke; P Reyniers; J Marquet
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

6.  Basal cell-specific and hyperproliferation-related keratins in human breast cancer.

Authors:  R H Wetzels; H J Kuijpers; E B Lane; I M Leigh; S M Troyanovsky; R Holland; U J van Haelst; F C Ramaekers
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

7.  Cytokeratin expression patterns in the human tympanic membrane and external ear canal.

Authors:  S Lepercque; D Broekaert; P Van Cauwenberge
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

8.  Cytokeratin expression pattern in congenital and acquired pediatric cholesteatoma.

Authors:  Ewa Olszewska; Jürgen Lautermann; Can Koc; Matthias Schwaab; Stefan Dazert; Henning Hildmann; Holger Sudhoff
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-03-08       Impact factor: 2.503

9.  An immunohistochemical and histochemical study of cytokeratin, involucrin and transglutaminase in seborrhoeic keratosis.

Authors:  D Broekaert; I M Leigh; E B Lane; G N Van Muijen; F C Ramaekers; J De Bersaques; P Coucke
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

10.  Immunohistochemistry, a valuable tool in detection of cervical lymph node micrometastases in head and neck squamous cell carcinoma: a prospective study.

Authors:  Anjani Kumar Sharma; Prakash Mishra; Shubha Gupta
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.